Global Paclitaxel Sales Market Report 2020

Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".
In the last several years, global market of Paclitaxel developed rapidly, with an average growth rate of 12.3%. In 2017, global revenue of Paclitaxel is nearly 80 M USD; the actual production is about 2600 Kg.

Market Analysis and Insights: Global Paclitaxel Market
The global Paclitaxel market size is projected to reach US$ 193.6 million by 2026, from US$ 117.4 million in 2020, at a CAGR of 8.7% during 2021-2026.

Global Paclitaxel Scope and Market Size
The global Paclitaxel market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Paclitaxel market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Paclitaxel market is segmented into
Natural Paclitaxel API
Semi-synthetic Paclitaxel API

Segment by Application, the Paclitaxel market is segmented into
Ovarian Cancer
Cervical Cancer
Breast Cancer
Other

The Paclitaxel market is analysed and market size information is provided by regions (countries). Segment by Application, the Paclitaxel market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape

and Paclitaxel Market Share Analysis
Paclitaxel market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Paclitaxel business, the date to enter into the Paclitaxel market, Paclitaxel product introduction, recent developments, etc.

The major vendors covered:
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius-kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology

Frequently Asked Questions



This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

  • By product type
  • By End User/Applications
  • By Technology
  • By Region

The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.

Please Select a Format

market Reports market Reports